Andreas Argaritis
Analyst, Oppenheimer
Replay available
MannKind Corporation (NASDAQ: MNKD) Q2 2025 earnings conference call, held 2025-08-06. Replay captured from the company's public earnings webcast.

Analyst, Oppenheimer
Analyst, HC Wainwright
Analyst, Kander Fitzgerald
Analyst
Chief Financial Officer
Chief Executive Officer
Analyst, Mizuho Americas
Good morning and welcome to the Mankind Corporation Second Quarter 2025 Financial Results Conference Call. As a reminder, this call is being recorded on August 6, 2025 and will be available for playback on the Mankind Corporation website shortly after the conclusion of this call and available for approximately 90 days. This call will contain the forward-looking statements. Such forward-looking statements are subject to risk and uncertainty, which can cause actual results to differ materially from these stated expectations. For further information on the company's risk factors, please see the Form 10Q for the quarterly period ended June 30, 2025, now on file with the SEC, the earnings release, and the slides prepared for this presentation. Joining us today for Mankind are Chief Executive Officer Michael Castagna and Chief Financial Officer Chris Prentice. I would now like to turn the conference over to Mr. Castagna. Please go ahead. Thank you, Operator, and good morning everybody. And thank you for joining us for our Second Quarter Earnings Call. As we look out, we're focused on creating more shareholder value, minimizing dilution, and enhancing our flexibility as we enter the next phase of our growth. The next six day quarters are going to showcase our cumulative work over the past seven years. Let me talk about the five pillars of our success. First, we're on the heels of Teton2 readout here in September, and we'll actually wait to those results as that provides upside to our current business plans in the future. Second, a Fresno's position for continued growth. PESA is now filed. I just want to put this in context. We target about 25% of all rapid acting scripts. 1% of the rapid acting market is roughly $300 million run rate in a Fresno. We have a strong balance sh...